641 results on '"Kahaly, George J."'
Search Results
2. Redox mechanisms in autoimmune thyroid eye disease
3. Recurrence risk of autoimmune thyroid and endocrine diseases
4. Pathophysiology of thyroid-associated orbitopathy
5. Immunoglobulin G4 and Graves’ Orbitopathy
6. Therapeutic Use of Levothyroxine: A Historical Perspective
7. Psychosomatik - neurobiologisch fundiert und evidenzbasiert
8. Teprotumumab for thyroid eye disease: early response is not required for benefit
9. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease
10. Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
11. Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
12. Homozygous Resistance to Thyroid Hormone β: Can combined anti-thyroid drug and triiodothyroacetic acid treatment prevent cardiac failure?
13. Homozygous Resistance to Thyroid Hormone β: Can Combined Antithyroid Drug and Triiodothyroacetic Acid Treatment Prevent Cardiac Failure?
14. Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials.
15. Heart in Hyperthyroidism
16. TSH Receptor Antibodies: Relevance & Utility
17. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors
18. Optimizing levothyroxine treatment for subclinical hypothyroidism during pregnancy
19. Versorgungsrelevante Daten einer interdisziplinären Sprechstunde für endokrine Orbitopathie
20. Autoimmune polyglandular diseases
21. Effect of a biofeedback intervention on heart rate variability in individuals with panic disorder: A randomized controlled trial
22. Effect of a Biofeedback Intervention on Heart Rate Variability in Individuals With Panic Disorder: A Randomized Controlled Trial
23. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
24. Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
25. Thyroid Inflammation and Immunity During the COVID-19 Pandemic: A Comprehensive Review and Case Study.
26. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
27. Graves’ disease
28. Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
29. Androgen Receptor regulates Ptpn22.
30. Optimizing levothyroxine treatment for subclinical hypothyroidism during pregnancy.
31. Diagnosis and Endocrine Management of Graves’ Disease
32. Hypothyreose beim Hausarzt: wie abklären, wie behandeln?
33. Preface for the 2023 BEEM issue on thyroid autoimmunity
34. Rapamycin improves Graves’ orbitopathy by suppressing CD4+ cytotoxic T lymphocytes
35. Immunotherapies for thyroid eye disease
36. Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
37. Osetljivost tri testa za određivanje antitela na receptor za tireostimulišući hormon kod pacijenata sa orbitopatijom udruženom sa štitnom žlezdom
38. A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease
39. Use of levothyroxine in the management of hypothyroidism: A historical perspective
40. Preface
41. OR11-4 Teprotumumab Markedly Improves Disease-related Quality of Life: Lessons From Two Randomized, Placebo-controlled Trials
42. Commentary: Brief report - Monoclonal antibodies illustrate the difficulties in measuring blocking TSH receptor antibodies
43. Graves' Orbitopathy: Pathophysiology, Clinical Presentation, and Management Paradigms
44. A novel point-of-care device accurately measures thyrotropin in whole blood, capillary blood and serum
45. 72 - Graves’ Orbitopathy
46. 71 - Graves Disease
47. Cardiovascular Hemodynamics and Work Capacity in Thyroid Dysfunction
48. Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease—Methodology and Clinical Applications
49. Autoantibodies against the calcium‐sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4
50. Autoimmune Polyglandular Syndrome Type 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.